Doseology Sciences Inc. (DOSEF)
Doseology Sciences Inc. is a Canadian firm dedicated to the cultivation and extraction of ingredients for both nutraceutical and pharmaceutical applications. The company's primary focus lies in the research, development, and commercialization of medicinal mushroom products, offered in various forms such as tinctures and powders. Customers can acquire these items directly through its official e-commerce platform, doseology.com. Founded in 2019, Doseology Sciences Inc. is headquartered in Kelowna, Canada.
Sector: Medical - Pharmaceuticals
Industry: Medical - Pharmaceuticals
Doseology Sciences Inc.
OTC:DOSEFHealthcare · Biotechnology
CLOSED
Mkt Cap-
EV-
Float1.94M
O/S4.5M
VOL350 sh
$ Vol$34
RVOL1.00×
Inst Own-
SI<0.1%
Net Cash/Sh+$0.03
Dilution
MCap-Float1.94MO/S4.5M
Dilution
Financials Summary
Revenue$73K
Net Income-$1.18M
Total Assets$194K
Free Cash Flow-$835K
Debt & Equity
Equity 100%
Total Debt$0
Total Equity$86K
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
- 1:10Reverse splitFeb 16, 202410 shares → 1
Balance Sheet Details
Assets$194K
Liabilities$107K
Accounts Receivable$54K
Accounts Payable$47K
Inventory$2K
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
| Revenue | $73K | $22K | $69K | $30K | $11K | $0 | $0 |
| YoY Growth | 232.6% | -68.3% | 128.7% | 168.5% | - | - | - |
| Cost of Revenue | $617K | $17K | $19K | $1K | $115K | $52K | $0 |
| Gross Profit | -$544K | $13K | $50K | $29K | -$104K | -$52K | $0 |
| Gross Margin | -747.6% | 60.4% | 73.2% | 95.8% | -924.6% | - | - |
| Research and Development | $0 | $2K | $0 | $350 | $43K | $79K | $0 |
| Selling, General, and Administrative | $546K | $299K | $245K | $532K | $1.03M | $953K | $296K |
| Other | $0 | $42K | $70K | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $546K | $343K | $315K | $611K | $1.17M | $1.1M | $296K |
| Operating Income (EBIT) | -$1.09M | -$242K | -$264K | -$537K | -$1.27M | -$1.1M | -$296K |
| Operating Margin | -1498.1% | -1108.2% | -383.3% | -1780.4% | -11277.5% | - | - |
| Interest Expense | $0 | $0 | $0 | $25K | $53K | $48K | $0 |
| Interest Income | $14K | $12K | $21K | $46K | $5K | $2K | $0 |
| Other Income (Expense) | -$87K | $12K | $26K | -$821K | $128K | -$44K | $0 |
| Income Before Tax (EBT) | -$1.18M | -$230K | -$238K | -$1.25M | -$1.36M | -$1.14M | -$296K |
| Income Tax Expense | $0 | $0 | $0 | $25K | $0 | $0 | $0 |
| Net Income | -$1.18M | -$230K | -$238K | -$1.25M | -$1.36M | -$1.14M | -$296K |
| Net Income Margin | -1618.1% | -1052.2% | -344.9% | -4134.7% | -12084.5% | - | - |
| Supplementary Data | |||||||
| EPS | -0.21 | -0.07 | -0.08 | -0.04 | -0.05 | -0.04 | -0.11 |
| Diluted EPS | -0.21 | -0.07 | -0.08 | -0.04 | -0.05 | -0.04 | -0.11 |
| Weighted Average OS | 7.98M | 4.61M | 4.26M | 41.10M | 39.10M | 41.00M | 3.70M |
| EBITDA | -$1.09M | -$230K | -$224K | -$1.26M | -$1.15M | -$978K | -$296K |
| EBITDA Margin | -1498.1% | -1052.2% | -324.3% | -4171.6% | -10270.7% | - | - |
Balance Sheet
| Period | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
| Assets | |||||||
| Current Assets | |||||||
| Cash and Cash Equivalents | $136K | $735K | $742K | $911K | $1.31M | $2.61M | $239K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $136K | $1M | $742K | $911K | $1.31M | $2.61M | $239K |
| Accounts Receivable | $54K | $29K | $2K | $12K | $31K | $567K | $567K |
| Inventory | $2K | $12K | $28K | $6K | $7K | $91K | $0 |
| Other Current Assets | $1K | $0 | $0 | $449K | $702K | $0 | $0 |
| Total Current Assets | $194K | $1.04M | $772K | $940K | $2.08M | $3.5M | $811K |
| Long-Term Assets | |||||||
| Property, Plant & Equipment Net | $0 | $0 | $0 | $39K | $618K | $635K | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $10K | $57K | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Assets | $0 | $0 | $0 | $39K | $628K | $692K | $0 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $194K | $767K | $772K | $979K | $2.71M | $4.19M | $811K |
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts Payable | $47K | $23K | $33K | $64K | $43K | $33K | $33K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $249K | $0 |
| Other Current Liabilities | $35K | -$9K | $0 | $0 | -$158K | $1.87M | $0 |
| Total Current Liabilities | $107K | $48K | $58K | $64K | $153K | $1.93M | $62K |
| Long-Term Liabilities | |||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $461K | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | -$452K | -$4K | -$461K | $0 |
| Total Long-Term Liabilities | $0 | $0 | $0 | $5K | $457K | $461K | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $107K | $66K | $58K | $69K | $610K | $2.39M | $62K |
| Stockholders' Equity | |||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $5.32M | $5.25M | $4.73M | $4.7M | $4.7M | $3.17M | $1.05M |
| Retained Earnings | -$5.82M | -$4.6M | -$4.28M | -$4.05M | -$2.8M | -$1.44M | -$302K |
| Comprehensive Income & Other | $580K | $238K | $0 | $257K | $199K | $76K | $0 |
| Other Stockholders' Equity | $580K | $324K | $270K | $257K | $199K | $76K | $0 |
| Total Equity | $86K | $978K | $714K | $910K | $2.1M | $1.8M | $750K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $194K | $1.04M | $772K | $979K | $2.71M | $4.19M | $811K |
| Supplementary Data | |||||||
| Total Debt | $0 | $0 | $0 | $35K | $522K | $481K | $0 |
| Net Debt | -$136K | -$735K | -$742K | -$876K | -$790K | -$2.13M | -$239K |
Cash Flow Statement
| Period | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Operating Activities | ||||||
| Net Income | -$1.18M | -$313K | -$238K | -$1.25M | -$1.36M | -$1.14M |
| Depreciation & Amortization | $0 | $0 | $14K | $46K | $98K | $65K |
| Deferred Income Tax | $0 | $0 | $0 | $186K | $2K | -$4K |
| Stock-Based Compensation | $0 | $68K | $12K | $58K | $60K | $14K |
| Changes in Working Capital: | ||||||
| Accounts Receivable | -$24K | -$27K | $10K | $48K | -$40K | $0 |
| Inventory | -$2K | $16K | -$22K | $1K | -$27K | -$90K |
| Accounts Payable | $16K | $0 | $0 | -$54K | -$197K | $0 |
| Other Working Capital | $2K | $5K | $34K | $100K | $65K | -$551K |
| Total Working Capital Change | -$9K | -$6K | $23K | $96K | -$199K | -$642K |
| Other Non-Cash Items | $351K | $75K | $24K | $524K | $199K | $48K |
| Net Cash from Operating | -$835K | -$176K | -$165K | -$337K | -$1.2M | -$1.66M |
| Investing Activities | ||||||
| Capital Expenditures | $0 | $0 | $0 | $0 | -$6K | -$119K |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $76K |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $17K |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $25K |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | -$17K |
| Net Cash from Investing | $0 | $0 | $0 | $0 | -$6K | -$18K |
| Financing Activities | ||||||
| Debt Repaid | - | - | $4K | $84K | $42K | - |
| Common Stock Issuance | $0 | $366K | $0 | $0 | $4.36M | $329K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | -$193K | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $0 | -$14K | -$70K | $0 |
| Net Cash from Financing | $0 | $366K | -$4K | -$98K | -$98K | $4.05M |
| Forex Effect | -$42K | $3K | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$877K | $193K | -$169K | -$401K | -$1.3M | $2.37M |
| Supplementary Data | ||||||
| Operating Cash Flow | -$835K | -$240K | -$165K | -$337K | -$1.2M | -$1.66M |
| Capital Expenditure | $0 | $0 | $0 | $0 | -$6K | -$119K |
| Free Cash Flow | -$835K | -$240K | -$165K | -$337K | -$1.2M | -$1.78M |
| Cash at Beginning | $1.01M | $542K | $911K | $1.31M | $2.61M | $239K |
| Cash at End | $132K | $735K | $742K | $911K | $1.31M | $2.61M |